RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Return
12.81%
This Quarter Return
+7.38%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.47B
AUM Growth
+$39M
(+2.7%)
Cap. Flow
-$26.1M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
26.19%
Holding
101
New
9
Increased
29
Reduced
33
Closed
7
Top Buys
| 1 |
Biogen
BIIB
|
$24.4M |
| 2 |
Veeva Systems
VEEV
|
$19.9M |
| 3 |
Pfizer
PFE
|
$19.6M |
| 4 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$13.1M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$12.3M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$41.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.4M |
| 3 |
NovoCure
NVCR
|
$13.3M |
| 4 |
LivaNova
LIVN
|
$12.2M |
| 5 |
Eli Lilly
LLY
|
$11.8M |
Sector Composition
| 1 | Healthcare | 94.98% |
| 2 | Industrials | 1.94% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
51
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $12M | 0.82% |
750,000
| – | – |
|
52
Xencor
XNCR
$597M
| $11.7M | 0.8% |
340,000
+105,000
| +45% | +$3.62M |
|
53
Becton Dickinson
BDX
$54.8B
| $11.7M | 0.79% |
49,200
-37,925
| -44% | -$9M |
|
54
Edwards Lifesciences
EW
$47.5B
| $11.4M | 0.77% |
110,000
| – | – |
|
|
ONEM
55
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $10.9M | 0.74% |
330,000
+130,000
| +65% | +$4.3M |
|
56
Neurocrine Biosciences
NBIX
$13.9B
| $10.2M | 0.69% |
105,000
-50,000
| -32% | -$4.87M |
|
57
Cassava Sciences
SAVA
$104M
| $9.83M | 0.67% |
+115,000
| New | +$9.83M |
|
58
Sangamo Therapeutics
SGMO
$160M
| $9.16M | 0.62% |
765,000
| – | – |
|
59
Baxter International
BAX
$12.1B
| $8.86M | 0.6% |
110,000
-80,000
| -42% | -$6.44M |
|
|
60
Bristol-Myers Squibb
BMY
$95B
| $8.35M | 0.57% |
125,000
-200,000
| -62% | -$13.4M |
|
|
IMGN
61
DELISTED
Immunogen Inc
IMGN
| $8.03M | 0.55% |
1,218,850
+668,850
| +122% | +$4.41M |
|
|
RVNC
62
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8M | 0.54% |
270,000
+50,000
| +23% | +$1.48M |
|
|
RDUS
63
DELISTED
Radius Health, Inc.
RDUS
| $7.84M | 0.53% |
430,000
| – | – |
|
64
Iovance Biotherapeutics
IOVA
$796M
| $7.81M | 0.53% |
300,000
+5,000
| +2% | +$130K |
|
65
Alkermes
ALKS
$4.77B
| $7.59M | 0.51% |
309,354
+100,000
| +48% | +$2.45M |
|
66
ESSA Pharma
EPIX
$11M
| $7.43M | 0.5% |
260,000
| – | – |
|
67
Dynavax Technologies
DVAX
$1.17B
| $7.39M | 0.5% |
750,000
-36,211
| -5% | -$357K |
|
|
GTHX
68
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $7.13M | 0.48% |
325,000
| – | – |
|
|
SILK
69
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.99M | 0.47% |
146,000
| – | – |
|
70
MeiraGTx Holdings
MGTX
$621M
| $6.98M | 0.47% |
450,000
| – | – |
|
71
Stereotaxis
STXS
$251M
| $6.6M | 0.45% |
684,402
| – | – |
|
72
Rigel Pharmaceuticals
RIGL
$720M
| $6.6M | 0.45% |
152,000
| – | – |
|
|
SWAV
73
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.45M | 0.44% |
33,990
-16,010
| -32% | -$3.04M |
|
74
Phathom Pharmaceuticals
PHAT
$851M
| $6.3M | 0.43% |
186,210
+11,210
| +6% | +$379K |
|
75
Zai Lab
ZLAB
$3.34B
| $6.2M | 0.42% |
35,000
-10,000
| -22% | -$1.77M |
|